HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zaid Smith Selected Research

Lerdelimumab

10/2007A phase III study of subconjunctival human anti-transforming growth factor beta(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zaid Smith Research Topics

Disease

2Fibrosis (Cirrhosis)
10/2007 - 10/2007
2Blister (Bulla)
10/2007 - 10/2007
2Angle-Closure Glaucoma (Glaucoma, Angle Closure)
10/2007 - 10/2007
1Cicatrix (Scar)
10/2007
1Glaucoma
10/2007
1Open-Angle Glaucoma (Glaucoma, Open Angle)
10/2007
1Wounds and Injuries (Trauma)
10/2007
1Stroke (Strokes)
01/2003

Drug/Important Bio-Agent (IBA)

1Fluorouracil (Carac)FDA LinkGeneric
10/2007
1Transforming Growth Factor beta2IBA
10/2007
1Anesthetics (Anesthetic Agents)IBA
10/2007
1Monoclonal AntibodiesIBA
10/2007
1Transforming Growth Factor beta (TGF-beta)IBA
10/2007
1LerdelimumabIBA
10/2007

Therapy/Procedure

2Trabeculectomy (Trabeculoplasty)
10/2007 - 10/2007
1Sutures (Suture)
10/2007
1Percutaneous Collagen Induction
10/2007
1Emergency Treatment
01/2003